Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Complete Genomics Logo
Complete Genomics Growth Score
91
CB Rank
242149
Heat Score
25
Complete Genomics, a life sciences company, develops and commercializes a DNA sequencing platform for human genome sequencing and analysis.
Acquired by
Swiss Rockets Logo
Swiss Rockets
Founded
obfuscation
DelistedSeries E Mountain View, California, United States251-500 www.completegenomics.com
Biotechnology
Genetics
Health Care
Health Diagnostics
Life Science
Overview

Complete Genomics
Total Funding
obfuscation
Growth Score
91
Heat Score
25

Total Funding
obfuscation
obfuscation
Series E raised
obfuscation
Growth Score91
13 pts
in past quarter
Heat Score 25
-61 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Complete Genomics

CB Rank
242149
Complete Genomics, a life sciences company, develops and commercializes a DNA sequencing platform for human genome sequencing and analysis.
Acquired by
Swiss Rockets Logo
Swiss Rockets
Founded
obfuscation
DelistedSeries E Mountain View, California, United States251-500 www.completegenomics.com
Biotechnology
Genetics
Health Care
Health Diagnostics
Life Science

Funding Rounds

Series E
OBF
in
obfuscation
Series D
OBF
in
obfuscation
Debt Financing
OBF
in
obfuscation

Key People

Details

Legal Name Complete Genomics Incorporated
Operating Status Active
Stock Symbol  NASDAQ:GNOM
Company Type For Profit
Founders  Clifford A. Reid, Radoje T. Drmanac
About the Company
Complete Genomics' high quality, affordable DNA sequencing enables commercial-scale research of the genetic mechanisms underlying drug responses and complex diseases. Complete Genomics combines innovative technology with a disruptive market approach that will revolutionize DNA sequencing.
Phone Number (650)284-2229
Contact Email info@completegenomics.com
Predictions & Insights

Growth Insight

See this Growth Insight
Complete Genomics is
Lorem
 to be growing
Top Contributing Factors
Operations Expansion

Products & Services

DNBSEQ Technology
A DNA sequencing technology using rolling circle replication to create DNA nanoballs for high-accuracy, PCR-free next-generation sequencing.
DNBSEQ-T7 Sequencing Platform
A high-throughput sequencing instrument producing up to 7 terabases of data per run for whole genome and multi-omics applications.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 6
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series E - Complete Genomics Logo
Series E - Complete Genomics
7
obfuscation
Sands Capital VenturesSeries E
obfuscation
Series E - Complete Genomics Logo
Series E - Complete Genomics
7
obfuscation
Sands Capital VenturesSeries E
obfuscation
Series E - Complete Genomics Logo
Series E - Complete Genomics
7
obfuscation
Sands Capital VenturesSeries E
obfuscation
Series E - Complete Genomics Logo
Series E - Complete Genomics
7
obfuscation
Sands Capital VenturesSeries E
obfuscation
Series E - Complete Genomics Logo
Series E - Complete Genomics
7
obfuscation
Sands Capital VenturesSeries E

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 6
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series E - Complete Genomics Logo
Series E - Complete Genomics
7
obfuscation
Sands Capital VenturesSeries E
obfuscation
Series E - Complete Genomics Logo
Series E - Complete Genomics
7
obfuscation
Sands Capital VenturesSeries E
obfuscation
Series E - Complete Genomics Logo
Series E - Complete Genomics
7
obfuscation
Sands Capital VenturesSeries E
obfuscation
Series E - Complete Genomics Logo
Series E - Complete Genomics
7
obfuscation
Sands Capital VenturesSeries E
obfuscation
Series E - Complete Genomics Logo
Series E - Complete Genomics
7
obfuscation
Sands Capital VenturesSeries E

Investors

M&A Details

Complete Genomics was acquired by Swiss Rockets on
obfuscation
.
Transaction Name 
Complete Genomics acquired by Swiss Rockets Logo
Complete Genomics acquired by Swiss Rockets
Acquired by 
Swiss Rockets Logo
Swiss Rockets
Announced Date 
obfuscation
Market Intelligence
People
View Profiles & Contacts
Headcount 251-500 Employee Profiles 2 Board Members and Advisors 14 Contacts 163

Employee Profiles

Board Members and Advisors

News

News and Press

News•Apr 29, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 29, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Mar 26, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Mar 3, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

1,826
-47.48%
 in past month

IT Spend

$1.9MThis year, Complete Genomics is projected to spend $1.9M on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Euronews Logo
Euronews
100
High Speed Networks Logo
High Speed Networks
100
Streaming Media Logo
Streaming Media
100

Actively Used Products

15Complete Genomics uses 15 technology products and services including HTML5, jQuery, and  Bootstrap, according to G2 Stack.

Active Website Tech Count

41Complete Genomics is actively using 41 technologies for its website, according to BuiltWith. These include Apple Mobile Web Clips Icon, DNSSEC, and  LetsEncrypt.

Total IP

157The intellectual property of Complete Genomics includes 150 registered patents primarily in the 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering' category, according to IPqwery. Additionally, Complete Genomics has registered 7 trademarks with the most popular class being 'Chemical substances', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Complete Genomics's headquarters? Complete Genomics is located in Mountain View, California, United States.Who invested in Complete Genomics? Complete Genomics has 7 investors including Essex Woodlands Healthcare Partners and  Highland Capital Partners.When was the last funding round for Complete Genomics? Complete Genomics closed its last funding round on
obfuscation
from a Series E round.Who are Complete Genomics's competitors? Alternatives and possible competitors to Complete Genomics may include Element Biosciences, Ultima Genomics, and  Oxford Nanopore Technologies.How much funding has Complete Genomics raised to date? Complete Genomics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(9fd75b2 1)
|